We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+12.54%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.79B
AUM Growth
+$28.8M
Cap. Flow
-$185M
Cap. Flow %
-6.63%
Top 10 Hldgs %
33.01%
Holding
105
New
22
Increased
19
Reduced
24
Closed
16

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$27.9M
2
A icon
Agilent Technologies
A
+$26.2M
3
ELV icon
Elevance Health
ELV
+$21M
4
CRL icon
Charles River Laboratories
CRL
+$15.9M
5
DXCM icon
DexCom
DXCM
+$14.9M

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$83.8M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$75.6M
3
AXSM icon
Axsome Therapeutics
AXSM
+$33.9M
4
VEEV icon
Veeva Systems
VEEV
+$33.4M
5
NVRO
NEVRO CORP.
NVRO
+$26.3M

Sector Composition

Rank Sector Weight
1 Healthcare 81.16%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JYAC
101
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
– –
-464,103
Closed -$4.63M
BLSA
102
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
– –
-464,103
Closed -$4.65M
1 2 3 4
5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
PWA
Pitcairn Wealth Advisors Conshohocken, Pennsylvania $1.09B AUM

PFM Health Sciences's Q4 2022 Portfolio in Review

As of Q4 2022, PFM Health Sciences held 105 positions worth $2.79B, up 1% from $2.76B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

PFM Health Sciences withdrew a net $185M in Q4 2022, closing 16 positions and reducing 24 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $83.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, down from 89% a quarter earlier, followed by Financials.

Against the trend, PFM Health Sciences opened a new position in Intuitive Surgical worth $30.4M.

  • PFM Health Sciences's largest Q4 2022 buy was Intuitive Surgical: 114,450 shares worth $30.4M.
  • PFM Health Sciences added most to Elevance Health in Q4 2022, an estimated $21M increase.
  • PFM Health Sciences's biggest Q4 2022 reduction was BioMarin Pharmaceuticals, cutting an estimated $75.6M.
  • PFM Health Sciences fully exited Jazz Pharmaceuticals in Q4 2022, selling an estimated $83.8M.
  • PFM Health Sciences's ten largest holdings make up 33% of its $2.79B portfolio in Q4 2022.
  • PFM Health Sciences opened 22 new positions and closed 16 in Q4 2022.
  • PFM Health Sciences's portfolio value rose 1% quarter-over-quarter to $2.79B.

Based on PFM Health Sciences's 13F filing for Q4 2022, filed 14 Feb 2023.